Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Jin, NY
Chaolun H. Jin, New York, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100131424 | SYSTEM AND METHOD FOR MANAGING AND INDEMNIFYING COMMERCIAL PAPER - In various embodiments, a computer-implemented method and system of managing and indemnifying commercial paper by a trustee over a computer network includes receiving, in a processor and over the network, an indication of a proposed short-term secured investment transaction from one or more parties to the transaction, said indication including one or more illiquid and non-current assets proposed as collateral for the investment transaction; evaluating, by the processor, an asset value of the one or more illiquid and non-current assets; applying, by the processor, a discount factor to the asset value in response to either an operator input or a predetermined discount factor stored in a database, or a combination thereof; determining, by the processor, whether the applied discount factor and a resulting discounted asset value is acceptable to the trustee and at least one party to the proposed secured investment transaction that is considering providing investment funds for the transaction; if the resulting discounted asset value is acceptable to the trustee and the at least one party, and if the proposed secured investment transaction is consummated, establishing, by the processor, a trust account in a database in which at least documents representing a transfer of title of the one or more illiquid and non-current assets are stored. | 05-27-2010 |
Meizhong Jin, Dix Hils, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110281888 | Fused Bicyclic Kinase Inhibitors - Compounds of Formula I, as shown below and defined herein: | 11-17-2011 |
Meizhong Jin, Dix Hills, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090163468 | Fused Bicyclic mTor Inhibitors - Compounds represented by Formula (I) | 06-25-2009 |
| 20090197864 | Furo- and Thieno [3,2-c] Pyridines - Furo[3,2-c]Pyridine and Thieno[3,2-c]pyridine compounds of Formula I, and pharmaceutically acceptable salts thereof, preparation, intermediates, pharmaceutical compositions, and use, such as in disease treatment, including cancers, including conditions in which EMT is involved, including conditions mediated by protein kinase activity such as RON and/or MET. | 08-06-2009 |
| 20090286768 | SUBSTITUTED IMIDAZOPYR- AND IMIDAZOTRI-AZINES - Fused pyridine-based bicyclic compounds having the structure of Formula I, as defined herein, pharmaceutically acceptable salts thereof, preparation, compositions, and disease treatment therewith. This abstract does not define or limit the invention. | 11-19-2009 |
| 20100099679 | FUSED BICYCLIC mTOR INHIBITORS - Compounds represented by Formula (I) | 04-22-2010 |
| 20110190496 | FUSED BICYCLIC mTOR INHIBITORS - Compounds represented by Formula (I) | 08-04-2011 |
| 20110218183 | Fused Bicyclic mTOR Inhibitors - Compounds represented by Formula (I) | 09-08-2011 |
Melzhong Jin, Dix Hills, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110224191 | Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines - Compounds of Formula I, as shown below and defined herein: (I) pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by Ron and/or Met. | 09-15-2011 |
Moonsoo M. Jin, Ithaca, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100075326 | YEAST SURFACE TWO-HYBRID SYSTEM FOR QUANTITATIVE DETECTION OF PROTEIN-PROTEIN INTERACTIONS - The present invention provides methods and related vectors and host cells for quantitative analysis of protein interactions in eukaryotic expression system. More specifically, the invention provides a yeast surface two-hybrid (YS2H) system that can express a pair of proteins, one protein (“bait”) as a fusion to a yeast cell wall protein, and the other (“prey”) in a secretory form. When two proteins interact in this system, they associate in the secretory pathway, and the prey that would otherwise be released into the media is captured on the cell surface by the bait. Expression of the bait and the prey proteins can be designed to promote a synchronized and comparable level of expression. The affinity of two interacting molecules can be quantitatively determined by two exemplary schemes: either flow cytometric detection of antibody binding to the epitope tags fused to the prey and the bait, or the readout from a protein-fragment complementation assay (“PCA”) such as complementation of split GFP fragments fused to the prey and the bait. | 03-25-2010 |
Weijun Jin, Brooklyn, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20120064556 | LIPOPROTEIN LIPASE ASSAY - The present invention is directed to a method and kit for the measurement of LPL. The method comprises the following steps; administering a dosage of an anti-coagulant to the subject, gathering the biological sample, adding the biological sample to a well of a well plate, adding a first buffer to the well plate, adding a second buffer to the well plate, adding a substrate to the well plate, incubating the well plate, measuring the fluorescence of the material within the well plate, and correlating the measured fluorescence to a level of LPL activity. The kit comprises the following elements; an anti-coagulant, a well plate, a first buffer, a second buffer, a substrate, and a correlator. | 03-15-2012 |
Wen Jin, Victor, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090302488 | METHOD AND APPARATUS FOR THE DRY RELEASE OF A COMPLIANT OPHTHALMIC ARTICLE FROM MOLD SURFACE - An apparatus for releasing a molded lens from a deformable mold includes a shear ring for temporarily retaining an annular portion of the deformable mold outside a periphery of the lens and a plunger for deforming an annular section of the deformable mold within the periphery of the lens. The apparatus can be employed to release a non-hydrated hydrogel lens from a deformable mold section. | 12-10-2009 |
| 20120001353 | METHOD AND APPARATUS FOR THE DRY RELEASE OF A COMPLIANT OPHTHALMIC ARTICLE FROM A MOLD SURFACE - An apparatus for releasing a molded lens from a deformable mold includes a shear ring for temporarily retaining an annular portion of the deformable mold outside a periphery of the lens and a plunger for deforming an annular section of the deformable mold within the periphery of the lens. The apparatus can be employed to release a non-hydrated hydrogel lens from a deformable mold section. | 01-05-2012 |
Xia Jin, Fairpoint, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100016253 | METHODS AND COMPOSITIONS RELATED TO HEIGHTENED APOBEC-1 RELATED PROTEIN (ARP) EXPRESSION - Disclosed are methods and compositions related to determining the status and mechanisms underlying long-term nonprogression of viral infections. | 01-21-2010 |
Xia Jin, Fairport, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100190147 | METHOD OF DETERMINING IMMUNE ENHANCEMENT OF VIRUS INFECTIVITY USING FC RECEPTOR-TRANSFECTED CELL LINES - The present invention relates to a method of detecting immune enhancement of virus infectivity, a method of determining neutralization and immune enhancement of virus infectivity, a method of identifying a virus epitope that displays immune enhancement, a method of identifying a compound that modulates activity of an Fc receptor, and a method of identifying a compound that modulates intracellular signaling of an Fc receptor. DNA constructs, cells, and kits relating to these assays are also disclosed. | 07-29-2010 |
Xin Jin, Pittsford, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20090035677 | CONDENSATION POLYMER PHOTOCONDUCTIVE ELEMENTS - The present invention relates to photoconductive elements having an electrically conductive support, an electrical barrier layer and, disposed over the conductive layer, a charge generation layer capable of generating positive charge carriers when exposed to actinic radiation. The electrical barrier layer, which restrains injection of positive charge carriers from the conductive support, comprises a crosslinkable condensation polymer having as a repeating unit a planar, electron-deficient, tetracarbonylbisimide group and optionally a crosslinker, | 02-05-2009 |
| 20100075247 | METHOD AND PREPARATION OF CHEMICALLY PREPARED TONERS - A method of making polymeric particles having a controlled size and size distribution, and in particular a method for the preparation of chemically prepared toners, via evaporative limited coalescence process, wherein basic silicate salts are employed to remove particulate stabilizer from precipitated polymer particles. The process includes the steps of dispersing polymeric binder materials and optional additives in an organic solvent to form an organic phase. The organic phase is dispersed by high shear agitation in an aqueous phase containing a particulate stabilizer, e.g. colloidal silica, to form a dispersion of small droplets of the organic phase in the aqueous phase. The dispersion is homogenized and the organic solvent is removed from the dispersed particles in the dispersion by evaporation, and polymeric particles are precipitated with particulate stabilizer on the surface thereof, which are then recovered, treated with a basic silicate salt to remove particulate stabilizer, and washed and dried. | 03-25-2010 |